The structure of cervical diseases in women suffering from pelvic floor dysfunction

Cover Page

Cite item

Full Text

Abstract

Background. The prevalence of pelvic floor dysfunction (PFD) is soaring steadily. The protrusion of the cervix beyond vaginal opening when exposed to environmental factors can lead to the development of dystrophic, sclerotic and neoplastic processes of the cervix, which are mediated by changes in the pH, biocenosis of the vagina and environmental factors.

Aim. To study the pathogenesis of cervical diseases in patients with PFD.

Materials and methods. The study design is an open-label prospective observational study. The study included 40 patients of reproductive age: 26 patients with cervical disease with PFD (PFD group), 14 patients without cervical disease and PFD made up the second group.

Results. The patients included in the study were comparable in terms of age and body mass index. Pap smear analysis revealed that the average number of leukocytes is significantly higher in patients with PFD compared to patients in the group without PFD – 5.5 (1.5–20.0) and 1.5 (1.5–6.5) respectively (p=0.040). In PFD group, a high prevalence of the following conditions was observed: cervical leukoplakia (15%), CIN1 (38.5%), CIN2 (8%), chronic cervicitis (38.5%). Onco-cytological test results reviewed where the high prevalence of parakeratosis and hyperkeratosis (15%), ASCUS (15%), LSIL (23%) and HSIL (8%) were also noteworthy. It was observed that human papillomavirus type 16 was predominant in PFD patient group.

Conclusion. The data obtained indicates an increased risk of developing cervical diseases in patients with PFD.

About the authors

Mekan R. Orazov

People’s Friendship University of Russia (RUDN University)

Email: omekan@mail.ru
ORCID iD: 0000-0002-1767-5536

D. Sci. (Med.), Prof.

Russian Federation, Moscow

Liliia R. Toktar

People’s Friendship University of Russia (RUDN University)

Email: toktarly@yandex.ru
ORCID iD: 0000-0003-4369-3620

Sci. (Med.)

Russian Federation, Moscow

Gulirano A. Karimova

People’s Friendship University of Russia (RUDN University)

Email: guliranon@icloud.com
ORCID iD: 0000-0001-7074-285X

Graduate Student

Russian Federation, Moscow

Dmitrii G. Aryutin

Bauman City Clinical Hospital №29

Email: aryutin@mail.ru
ORCID iD: 0000-0001-5747-9583

Cand. Sci. (Med.)

Russian Federation, Moscow

O’Tosin M. Apata

Bauman City Clinical Hospital №29

Email: tosinonyx@icloud.com
ORCID iD: 0000-0002-4395-9655

obstetrician-gynecologist

Russian Federation, Moscow

Irina A. Mullina

People’s Friendship University of Russia (RUDN University)

Author for correspondence.
Email: 211irina2111@rambler.ru
ORCID iD: 0000-0002-5773-6399

Clinical Resident

Russian Federation, Moscow

References

  1. Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2020;46(1):5-14. doi: 10.1590/S1677-5538.IBJU.2018.0581
  2. Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24(11):1783-90. doi: 10.1007/s00192-013-2169-9
  3. Wu JM, Vaughan CP, Goode PS, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123(1):141-8. doi: 10.1097/AOG.0000000000000057
  4. Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278-83. doi: 10.1097/AOG.0b013e3181c2ce96
  5. Камоева С.В. Патогенетические аспекты прогнозирования, диагностики и лечения пролапса тазовых органов. Дис. … д-ра медицинских наук. 2015 [Kamoeva SV. Pathogenetic aspects of prognosis, diagnosis and treatment of pelvic organ prolapse. Dis. … dr. med. sciences. 2015 (in Russian)].
  6. Fang G, Hong L, Liu C, et al. Oxidative status of cardinal ligament in pelvic organ prolapse. Exp Ther Med. 2018;16(4):3293-302.doi: 10.3892/etm.2018.6633
  7. Mahajan G, Kotru M, Batra M, et al. Usefulness of histopathological examination in uterine prolapse specimens. Aust N Z J Obstet Gynaecol. 2011;51(5):403-5. doi: 10.1111/j.1479-828X.2011.01337.x
  8. Grigoriadis T, Valla A, Zacharakis D, et al. Vaginal hysterectomy for uterovaginal prolapse: what is the incidence of concurrent gynecological malignancy? Int Urogynecol J. 2015;26(3):421-5. doi: 10.1007/s00192-014-2516-5
  9. de Castro EB, Brito LGO, Giraldo PC, Teatin Juliato CR. Does the Vaginal Flora Modify When a Synthetic Mesh is Used for Genital Prolapse Repair in Postmenopausal Women? A Pilot, Randomized Controlled Study. Female Pelvic Med Reconstr Surg. 2019;25(4):284-8. doi: 10.1097/SPV.0000000000000539

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Cytological examination in patients with PFD and cervical diseases.

Download (85KB)
3. Fig. 2. Histological test results in patients with PFD.

Download (72KB)

Copyright (c) 2021 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).